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ABSTRACT 
 
DOWDYE, AYANAH    Glucocorticoid polymorphisms assessed in overweight populations as 
compared to normal populations. 
Department of Biological Sciences, June 2018 
 
ADVISOR: Brian Cohen 
 
 The glucocorticoid receptor (GR) is part of a family of nuclear receptors that control gene 
expression. In the presence of the steroid hormone cortisol, certain genes are expressed; the 
products of which control certain features of the body, including but not limited to, blood pressure, 
serum triglycerides, and blood sugar. There is evidence that these features are major contributors to 
obesity. Specific polymorphisms of the GR and other regulators of either GR or the closely related 
mineralocorticoid receptor such as heat shock protein 90 and 11ß-hydroxysteroid dehydrogenase 
type 1 have been found in our labs and others to be present at a higher frequency in obese 
populations. Our current research is investigating polymorphisms in these genes as well as the gene 
encoding the FK506 binding protein (FKBP) which works in conjunction with HSP90 to negatively 
regulate GR activity. This finding in combination with previous results will lead to a better 
understanding of the genetic underpinnings of obesity and may reveal novel therapeutic approaches.  
 In this research, participants from Ellis Bariatrics Hospital allowed us to collect DNA from their 
cheek cells, that were then isolated t run through PCRs to analyze whether or not mutations were 
present in these subjects. With the polymorphisms tested, there was an increase in mutant allele 
frequency in our bariatric sample for FKBP51, decreased frequency for BclI, and no mutations 
present for TthIII.  
Keywords: bariatrics, cortisol, Cushing’s Syndrome, DNA isolation, gel electrophoresis, 
glucocorticoid receptor (GR), hypothalamic pituitary adrenal (HPA) axis, Metabolic Syndrome 
(MetS), obesity, polymerase chain reaction (PCR), single nucleotide polymorphism (SNP) 
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Introduction: 
The obesity epidemic has been around for many years, and continues to be an issue even in 
today’s society. Obesity is defined as a given point where a specific weight for a defined 
height has been exceeded. You present with having excessive fat around that body that is 
not what you would see among the average population. In 2015, a worldwide estimate of 
107.7 million children and 603.7 million adults have been reported to be obese (1). Since 
1980, obesity rates have nearly doubled in approximately 70 countries, and continues to 
increase in many countries as well. It has been reported that a high body mass index (BMI) 
was reported as a contributing factor in 4 million deaths around the globe in 2015, and 60% 
of those individuals were reported to be obese (1).  
 According to more recent studies, the US has the highest average BMI among all high-
income countries (2). Despite this, and the ongoing efforts to educate the general public, as 
of 2011, 34% of the adult US population, and nearly 20% of child/adolescent populations 
are obese (3).  This is an important issue because obesity increases the risk of many diseases 
in obese individuals, such as cardiovascular diseases, diabetes, and cancers among others. 
This is an urgent public health issue, and due to the complexity of obesity, this has the 
potential to be one of the most complicated health issues we have had to face. 
Obesity also impacts the US economy due to its extreme impact on the healthcare system. 
The national estimated medical cost in 2008 for obesity related treatment efforts were 
approximately $147 billion, but can range from $147 billion to $210 billion annually (4). 
Direct medical costs include, but are not limited to, preventative, diagnostic and treatment 
services related to obesity, while indirect economic costs revolve around lack of 
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productivity in the workforce due to being absent from work for obesity related health 
issues, decreased productivity of obese employees while at work, or premature mortality (4).  
Some individuals suffering from obesity decide to undergo bariatric surgery. In essence, 
this treatment physically decreases the size of their stomach, thus decreasing the amount of 
food that makes the individual feel full, decreasing their caloric intake and ultimately 
allowing for weight loss. There are three different surgical methods that we will be 
analyzing in this research project. The LAP Band is the least invasive of the three surgical 
methods. It requires the surgeon to place an inflatable ring around the patient’s stomach to 
reduce the size of the stomach, to make you feel fuller with less amount of food (11). The 
surgeon can adjust the size of the band as necessary, and can be reversed if wanted (11). 
Next is the vertical sleeve gastrectomy, where the surgeon removes a large portion of the 
patient’s stomach, which will leave a banana shaped portion enclosed with staples (11). This 
method allows one to feel fuller sooner, but unlike the LAP band, cannot be reversed (11). 
The third method is the roux-en-y gastric bypass. It allows one to feel full sooner while 
eating less food. The surgeon staples the stomach in order to create a small pouch in the 
upper part of your stomach. Then, the small intestine gets cut and attaches to the small 
pouch directly, in order to bypass most of the stomach (11).  This will also change the gut 
bacteria to influence appetite and metabolism  
As previously mentioned, obese individuals are more susceptible to certain diseases and 
illnesses. Metabolic syndrome (MetS) is a specific type of medical problem that obese 
people typically face. MetS is not defined as a disease, but rather a cluster of symptoms or 
risk factors. The 5 factors that are part of the  MetS constellation are high blood pressure, 
high blood sugar, low HDL cholesterol levels, high triglyceride levels, and increased 
 6 
centripetal (or abdominal) fat (5). Having one of these risk factors does not mean you have 
MetS, but rather having at least 3 of the 5 risk factors may imply that you do indeed have 
MetS. 
 
Figure 1. Distribution of cases of obesity related diseases. This demonstrates the overlap 
 between MetS and obesity. 
 
However, these risk factors are largely defined by lifestyle. Surplus food intake, 
sedentary life habits, and overall unhealthy lifestyles greatly contribute to MetS (5). While it 
most commonly occurs in obese individuals, one does not have to be obese to suffer from 
MetS.  
MetS can be found in some Cushing’s syndrome patients. Symptoms of cushing’s 
syndrome include, but are not limited to, weight gain around the stomach (but not much 
around the arms and legs), high blood pressure, “buffalo hump”, muscle weakness, purple 
striae, irritability, red face, poor concentration and more (6). Cushing’s syndrome is a state 
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of having too much cortisol in the bloodstream, for long periods of time, otherwise known 
as hypercortisolemia. This most commonly is due to an over activation of the hypothalamic-
pituitary-adrenal axis, or HPA axis (7).  
The HPA axis is an important hormonal response system that allows your body to 
respond during periods of stress (9). The function of this hormonal response system is to 
allow the body to respond rather quickly to a situation that is interpreted as stressful (9). The 
HPA axis is outlined in figure 2.  
 
Figure 2. The Hypothalamic Pituitary Adrenal axis. This axis allows for the regulation of 
 cortisol within the body. Stress is perceived, CRF is released, POMC is produced, gets 
 cleaved into the hormone ACTH, and cortisol is eventually released 
 
A stress stimulus is perceived by the brain, which then activates the hypothalamus. The 
hypothalamus then releases a hormone called corticotropin-releasing factor (CRF). CRF 
then finds its way to the anterior pituitary gland, where it stimulates the production of a 
protein called proopiomelanocortin (POMC), which is then cleaved to produce a hormone 
called adrenocorticotropic hormone (ACTH). ACTH then stimulates the adrenal gland, and 
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from the adrenal gland, you get the release of cortisol, a key contributor as a response 
hormone to stressful situations (9).  
Cortisol is a steroid hormone produced by the adrenal glands (8).  The purpose of cortisol 
is not only to help the body respond to stress, but also maintain blood pressure, maintain the 
immune system, and convert fat, carbs, and proteins into energy (8). Cortisol is a specific 
hormone under the umbrella term of glucocorticoids. As previously mentioned, 
hypercortisolemia is the underlying cause of Cushing’s syndrome. MetS can be commonly 
found in most patients that suffer from Cushing’s syndrome. However, we have found most 
peculiar at this time is that with Cushing’s syndrome, you have hypercortisolemia, whereas 
with MetS, cortisol levels are normal. But sometimes, even though cortisol is normal, 
patients may still present as if they did indeed have hypercortisolemia. This requires one to 
know how hormones work.  
Hormones are analogous to a key and a lock. Every hormone has its receptor. For 
example, cortisol’s receptor is called the glucocorticoid receptor (GR). Once a hormone 
binds to its receptor, it triggers a series of events that causes the body to respond to that 
hormone. With that being said, we mentioned that with MetS patients, there isn’t a presence 
of excess cortisol present, but sometimes, the body will respond as if there was a lot of that 
hormone. Which leads us to ask, how exactly is that phenomena happening?  
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Researchers have found that there may be a link between stress and obesity. More 
specifically, stress has been linked to bodily biological changes, that lead individuals to 
have cravings that can potentially lead to obesity.  
 
Figure 3. The cyclical nature of stress as it relates to cortisol. High stress levels cause 
 the release of extra cortisol, which leads to excess fat storage, which can contribute to 
 obesity. 
 
This phenomenon has been noticed on numerous occasions in daily life. Refer to figure 3 
above. People tend to have cravings for particular “comfort foods” that are typically either 
high in fat or high in sugar content. (10). This is in part due to cortisol, with its ability to not 
only manage fat storage and energy, but also known to increase appetite, and possibly 
increase cravings for sugar or fat (10).  
We know that people that have an excess level of cortisol in the body can lead to a certain 
kind of obesity that we have already mentioned before, Cushing’s Syndrome, which is 
accompanied by centripetal obesity. However, it is also noted that centripetal obesity can 
also be found in patients suffering with MetS. This lead the researchers in our lab to propose 
that MetS could possibly just be a subclinical Cushing’s Syndrome. While individuals with 
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MetS may not have the hypercortisolemia, they somehow still have many of the same 
features as a Cushing’s patient. Thus, these individuals are suffering with symptoms of 
hypercortisolemia without the excess cortisol. Rather, they have very normal cortisol levels. 
How can someone experience symptoms of hypercortisolemia without excess cortisol? 
Since we know that hormones work directly with a receptor, we proposed that something 
mechanistically can be malfunctioning with the receptor. It is possible that the receptor is 
hypersensitive to cortisol, and over expresses its function with even normal levels of 
cortisol. Because of this, we wanted to investigate whether or not people who have a 
tendency toward MetS have polymorphisms in their glucocorticoid receptors (GRs) that 
could make them more susceptible to obesity with their hypersensitive GRs to cortisol. This 
would allow the expression of the hypercortisol phenotype, or conversely, if these 
individuals have a lack of resistance polymorphisms, that can allow for the hypercortisol 
phenotype. In addition to this, our researchers are also interested in the idea that individuals 
that undergo bariatric surgery to cure their obesity sometimes end up regaining the weight 
right back. This lead us to hypothesize whether or not there could be a risk of weight regain 
associated with different GR polymorphisms. 
With the direction medicine is going in, the future of medicine is personalized genomic 
medicine. To be able to help treat a patient based off of their own genetic makeup is the best 
and most effective way to treat someone. Thus, if we know that a patient has a genetic 
makeup that makes them susceptible to weight regain, we can try different methods of 
surgery depending on what we know would be best for that particular genetic makeup. This 
allows physicians and other healthcare professionals to make more informed choices about 
medical care if provided with some additional information. Within the context of this 
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research, we mentioned four different methods of bariatric surgery: the roux-en-Y gastric 
bypass, the laparoscopic adjustable gastric band (lac band), the sleeve gastrectomy, and the 
duodenal switch. If someone was successful with a lac band, and then removed the band, 
only to regain the weight, this can lead the person to feel depressed, and keep gaining 
weight, until a new method of surgery is required. If we knew that a person’s genetic 
sequence makes them more susceptible to regaining weight if they were using lac band, then 
we would be able to immediately move on to a more invasive surgical method from the 
beginning, in order to skip the weight loss/ weight regain phases that the individual may 
come across. To be able to successfully do this would save individuals a lot of time, money, 
and mental exhaustion. Overall, this research has real medicinal implications that can be 
quite beneficial to the future of medicine. 
 
Experimental Approach: 
There is a total of 7 different SNPs that we wanted to look into in this research project. If 
these types of mutations are prevalent in more obese populations, this could help support the 
idea that this could play a role in the development of obesity. We hypothesized that 
polymorphisms at the cortisol receptors can lead to this oversensitivity of these receptors, or 
the resistance at these receptors of cortisol, which may contribute to obesity. The 7 different 
SNPs that we have identified, by colloquial polymorphism names, are BclI, N363S, TthIII1, 
RS120, RS84, RS207s, and MR55s. The chart below provides information regarding the 
mutated gene, the phenotypic expression of the mutated receptor, the location of the 
mutation, among other information.  
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We ran the samples to see how many of these patients have the mutation for each of the 7 
polymorphisms we are testing. As previously mentioned, the DNA samples came from 
either patients that have already undergone bariatric surgery or are thinking of undergoing 
bariatric surgery. From there, we conducted analyses to see if there were any correlations 
between these obese patients and the propensity toward mutated glucocorticoid receptors. 
Due to time constraints however, we only had the time to test out 3 of our polymorphisms, 
which is discussed further in our results section. 
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Materials and Methods: 
DNA Extraction 
The patient population we have pulled our DNA samples from come from Ellis Bariatric 
Hospital in Niskayuna, NY. We introduced ourselves as research students at Union College, 
followed by an overview of our research, and details on how to participate in our study if 
they so choose. These individuals were people that have either have already undergone or 
are seriously considering undergoing bariatric surgery.  
We started the process of obtaining our data by extracting DNA from our patient sample 
population. We started by swabbing the inside of the patient’s mouths for 15 – 30 seconds. 
Then we cut the swab handle, and put the swab side inside of a 1.5mL microcentrifuge tube. 
Since we typically did not perform the DNA extraction the same day, swabs were stored at  
4 °C. 
 When we were ready to perform the DNA extraction, we added 600uL of 50mM 
NaOH. Then we closed the microcentrifuge tubes containing the brush and vortexed the mix 
for 10 minutes. After that, the tubes were then heated at 95°C for an additional 10 minutes. 
Next, we added 120uL of 1M Tris at a pH of 8.0 to the tube, and we removed and discarded 
the swab at this point. This was the extracted DNA samples that were used to continue with 
our research. We used approximately 2-3uL of DNA to run our reactions. 
Polymerase Chain Reaction 
Now that we had our extracted DNA samples, we could perform our Polymerase Chain 
Reactions (PCRs). For each DNA sample, we needed to have two PCR tubes, one for our 
wildtype (WT) primers and one for our mutant (MU) primers. So if we were running 8 DNA 
samples, we needed 16 PCR tubes. We added 2uL of DNA to each tube. We then created a 
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large mix in a microcentrifuge tube containing water, dNTPs, our common primer, 10X 
buffer, 5X Q solution (if needed, otherwise replaced with just water), and Taq polymerase 
depending on how many reactions we wanted to run. Then the mix was split into two. We 
then added our WT primer to one mix and the MU primer to the other mix. Then, we had 
put 13uL of each mix into their respective tubes (the WT mix would go into the PCR tube 
labeled WT, and likewise for the MU), so that the total amount in the tube was 15uL. The 
amount of each element in each tube was as follows: 
     10X Buffer: 1.5uL 
     5X Qsol: 3uL 
     dNTPs: 0.3uL 
     Taq Polymerase: 0.075uL 
     Water: 5.125uL 
     Common Primer: 1.5uL 
     WT or MU Primer: 1.5uL 
     DNA: 2uL 
 
     Total: 15uL 
 
The purpose of PCRs is to make billions of copies of a segment of DNA in a matter of 
hours. It works in a series of three step processes: denaturation, annealing and extension. 
For denaturation, the temperature is high enough to unwind the DNA. For the annealing 
process, the temperature is lowered so that the primers (complementary to a short part of 
DNA that we wanted to amplify) can attach to the sequence that we were targeting. Then 
extension step, otherwise known as the elongation step, which is run at a higher temperature 
than that of the annealing step but lower than denaturation, takes the Taq polymerase (which 
moves along the strand of the DNA) and adds nucleotides to the annealed primer. This 
process repeats numerous times over a period of 3 hours to make billions of copies of the 
segment we targeted.  
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Running Our Agarose Gels 
Once our PCRs were done, we added 3uL of DNA loading dye to each sample, so that we 
could visually see the bands. At this point, they were ready to be loaded into our agarose 
gels. We ran our products on 2% agarose gels, which were made in the lab. From there, we 
loaded the DNA ladder into the first lane, and the middle lane. Then the DNA samples were 
loaded side by side, by putting the WT products in the left lane, and the MU products in the 
adjacent right lane. We did this across the entire gel, or until all of our samples were all 
loaded. Then, by a process called gel electrophoresis, we ran our samples until they had 
separated far enough down the lane to be able to be differentiated. Gel electrophoresis takes 
advantage of the fact that DNA is negative, due to the backbone of the DNA, and thus the 
DNA ‘runs’ toward the positive electrode to separate. After the bands had been separated, 
they could be visualized in the gel visualizer for our DNA analysis. 
 
Results: 
While we had planned to run 7 different polymorphisms, we only had the opportunity to 
run through three: FKBP51, BclI, and TthIII1. In each of the gels starting at the left, patient 
1 is represented in the first 2 lanes, patient 2 in the next 2 lanes, etc. The ladders are 
indicated with the arrows in each of the figures. For each patient, and for each pair of lanes, 
WT was loaded in the leftmost lane, while MU was loaded in the rightmost lane. If there is 
only a band in the left lane and not the right lane, then the genotype is homozygous WT. If 
there is only a band in the right lane, then the genotype is homozygous MU. If the band is 
present in both lanes, then the genotype is heterozygous. These gels provide the raw data 
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that needed to be analyzed. While I do not include all of our gels, representative gels are 
seen below. 
 
 
 
 
 
 
 
Figure 4. The patient DNA samples were run on 2% agarose gels. The top figure is to see 
 detect any FKBP51 polymorphisms, the middle gel is to detect any BclI polymorphisms, 
 the bottom gel is to detect any TthIII1 polymorphisms. 
 
From the agarose gels, we had extracted the data and recorded the allele frequencies for 
each of the 3 polymorphisms. The blue section represents the frequency of the normal WT 
allele being expressed in the dataset. The orange section represents the frequency of the 
abnormal MU allele being expressed in the dataset. The normal population data is found in 
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the left column, which were obtained from statistics from the National Institute of Health. 
The overweight population data is found in the right column, which were obtained from 
willing volunteers at Ellis Bariatric Hospital. To get this data, we summed up how many 
times the WT allele or the MU allele appeared in each polymorphism, and calculated 
proportions from there.  
 
 
 
 
 
 
 
 
 
 
Figure 5. Allele SNP frequencies as compared between normal populations and our 
 bariatric patient sample. The normal populations were extracted from the National 
 Institute of Health data, with an N = 1000. Our bariatric patient samples were taken from 
 Ellis Bariatric patient participants, with an N = 18. 
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Discussion: 
Recall that our initial hypothesis was that SNPs associated with increased cortisol activity 
will be detected more frequently in overweight populations than that of normal weighted 
counterparts. As the data suggests, this is partially true, but there is not enough data to 
completely support this claim.  
An important concept to know is that every hormone is only as good as it’s receptor. The 
slightest of changes in its composition can change the overall efficacy of the receptor. The 
GR has a structured binding pocket of the glucocorticoid hormones, as illustrated in the 
image below. 
 
 
Figure 6. The glucocorticoid receptor has a binding pocket for different hormones. 
 Changing the composition of the receptor can change how well the hormone will bind to 
 the receptor. 
 
Mutations in the structure of the GR can result in a phenotypic different in either 
overexpressing or under expressing glucocorticoids. From the data provided above, we have 
noticed that there was a higher occurrence of the FKBP51 MU allele in the bariatric patient 
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population sample that we collected, as opposed to the normal NIH data. Conversely, we 
found a lower frequency for the BCl1 MU allele in our bariatric patient population as 
opposed to the normal sample. And the most interesting data that we noticed was that the 
TthIII MU allele did not show up in our bariatric patient population at all.  
When we thought about the data in greater detail, we deduced that it would support our 
hypothesis that the bariatric patient sample had a higher rate of occurrence of the MU allele 
for FKBP51 due to the fact that this protein interacts with other regulator complexes, such 
as HSP90, as a chaperone protein. Together, with the HSP90 complex, the affinity of 
cortisol to the GR changes. The 52 is a positive regulator that increases the affinity of 
cortisol to the GR, whereas the 51 is a negative regulator, reducing the affinity of the 
cortisol to the GR. Thus, if we hypothetically had a polymorphism that displayed the effects 
of hypercortisolemia, it could lead to obesity. If we hypothesized correctly, it would make 
sense for the bariatric population to have a higher occurrence of the FKBP51 mutation.  
As for the BCl1 polymorphism, we would have expected that the bariatric patients had a 
higher frequency of this polymorphism, because a mutation in the BCl1 gene would have 
led to a hypersensitivity phenotype, indicating that with normal levels of cortisol, they were 
expressing hypercortisolemia. However, the data do not support this claim.  
Finally, we were surprised that there were no TthIII mutations in our bariatric patient 
sample. After closer reflection, however, we realized that TthIII is a resistance 
polymorphism, indicating that while we are not seeing more hypersensitivity, we are seeing 
less resistance in our bariatric patient sample. This could also lead to a propensity toward 
hypercortisolemia, which is on par with our hypothesis. Let it be noted however, that our 
data may not be statistically significant at this point, due to our small patient sample 
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population, however it does give us hope for further research in the future to see if there are 
any clearer trends that come to the surface.  
Unfortunately, although Claude and I wanted to analyze different aspects of the research, 
due to the time constraints, I did run out of time to look for any significant trends between 
the presence of these polymorphisms, and the propensity toward weight regain after surgery 
amongst the different bariatric surgery techniques that had been performed.  
Each one of our polymorphisms had to be run on their own gels. Our TthIII on one gel, 
FKBP51 on another, BCl1 on another, etc. This takes up a lot more time because each PCR 
reaction takes about 3 hours to run, each gel about 30 minutes to make, and has to run for 
about no less than 30 minutes before it can be analyzed. However, if there was somehow a 
way to test two different polymorphisms that run through the PCR at the same temperature, 
with different expected product sizes, that could save a lot more time for data analysis. 
Thus, a multiplex assay was designed in order to do just this. We ended up getting one 
successful multiplex assay with FKBP51 and BCl1.  
             
Fig 3. Gels show the multiplex assay for subject number 10. BCl1 and FKBP51 were first 
 run separately to reveal the genotype for subject 10. Then they were combined to reveal 
 the same genotype in the multiplex assay. 
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Two SNPs were put into a single reaction that created two separate and distinct sets of 
bands on the gel. The important considerations here are that these two primers were for 
different genes, that they both contain the same optimal annealing temperature, and they 
have distinguishable molecular weights to be able to tell the bands apart.  
As for future directions of this research, we hope to optimize the multiplex procedure. 
This would help to save on materials as well as the amount of time it takes to get the raw 
data collected for data analysis. We also hope to be able to design primers that can run both 
the WT and MU alleles in the same lane, which again would save on both time and 
materials for this research. Additionally, we would hope to obtain more patient samples in 
the future. We got 40 DNA samples this year, however not all of the DNA was working 
with the primers, which could have been a mistake when isolating the DNA. Only 18 of our 
DNA samples worked consistently. Finally, we would hope to obtain more significant 
correlations toward the weight propensity and weight regain angle of this research. 
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